Functional Implications of MicroRNA-215 in TGF-β1-Induced Phenotypic Transition of Mesangial Cells by Targeting CTNNBIP1

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mu, Jiao ^a   Pang, Qi ^a   Guo, Yan Hong ^a   Chen, Ji Gang ^a   Zeng, Wei ^a   Huang, Yong Jun ^a   Zhang, Jun ^a   Feng, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; CATENIN BETA INTERACTING PROTEIN 1; FIBRONECTIN; LUCIFERASE; MICRORNA; MICRORNA 192; MICRORNA 215; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ASSAY; GENE EXPRESSION REGULATION; GENE SILENCING; GLOMERULUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ACTINS; ANIMALS; BETA CATENIN; CELL CYCLE PROTEINS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; FIBRONECTINS; GENE SILENCING; GLOMERULAR MESANGIUM; MICE; MICRORNAS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84874830679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058622     Document Type: Article

References (64)

1. Balakumar P, Arora MK, Reddy J, Anand-Srivastava MB, (2009) Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism. J Cardiovasc Pharmacol 54: 129-138.
2. Fogo AB, (1999) Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 7: 147-159.
3. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC 3rd, (2008) From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57: 1439-1445.
4. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, et al. (1997) Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12: 43-50.
5. Simonson MS, (2007) Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int 71: 846-854.
6. Mishra R, Cool BL, Laderoute KR, Foretz M, Viollet B, et al. (2008) AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation. J Biol Chem 283: 10461-10469.
7. Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, et al. (2010) NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21: 93-102.
8. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN, (1998) Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Kidney Int 54: 1107-1116.
9. Floege J, Johnson RJ, Couser WG, (1992) Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. Clin Investig 70: 857-864.
10. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, et al. (1992) The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol 2: S190-197.
11. Chen S, Jim B, Ziyadeh FN, (2003) Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23: 532-543.
12. Ziyadeh FN, (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15Suppl 1: S55-57.
13. Sharma K, Ziyadeh FN, (1995) Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44: 1139-1146.
14. Mishra R, Simonson MS, (2008) Oleate induces a myofibroblast-like phenotype in mesangial cells. Arterioscler Thromb Vasc Biol 28: 541-547.
15. Amrouche L, Bonifay R, Anglicheau D, (2011) [MicroRNAs in pathophysiology of renal disease: an increasing interest]. Med Sci (Paris) 27: 398-404.
16. Inui M, Martello G, Piccolo S, (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
17. Li JY, Yong TY, Michael MZ, Gleadle JM, (2010) Review: The role of microRNAs in kidney disease. Nephrology (Carlton) 15: 599-608.
18. Bhatt K, Mi QS, Dong Z, (2011) microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 300: F602-610.
19. Sun Y, Koo S, White N, Peralta E, Esau C, et al. (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 32: e188.
20. Kato M, Zhang J, Wang M, Lanting L, Yuan H, et al. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104: 3432-3437.
21. Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, et al. (2010) E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 59: 1794-1802.
22. Kato M, Wang L, Putta S, Wang M, Yuan H, et al. (2010) Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. J Biol Chem 285: 34004-34015.
23. Kim YS, Reddy MA, Lanting L, Adler SG, Natarajan R, (2003) Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice. Kidney Int 64: 1702-1714.
24. Wu D, Peng F, Zhang B, Ingram AJ, Kelly DJ, et al. (2009) PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells. J Am Soc Nephrol 20: 554-566.
25. Herrera BM, Lockstone HE, Taylor JM, Wills QF, Kaisaki PJ, et al. (2009) MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes. BMC Med Genomics 2: 54.
26. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, et al. (2006) Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 17: 2484-2494.
27. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, et al. (2009) Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008.
28. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
29. Long J, Wang Y, Wang W, Chang BH, Danesh FR, (2011) MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J Biol Chem 286: 11837-11848.
30. Osman A, Falker K, (2011) Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 22: 433-441.
31. Chen XM, Splinter PL, O'Hara SP, LaRusso NF, (2007) A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 282: 28929-28938.
32. Chen XM, O'Hara SP, Nelson JB, Splinter PL, Small AJ, et al. (2005) Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 175: 7447-7456.
33. Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, et al. (2010) Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer 9: 96.
34. Wong CF, Tellam RL, (2008) MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 283: 9836-9843.
35. Daniels DL, Weis WI, (2002) ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. Mol Cell 10: 573-584.
36. Schagger H, (2006) Tricine-SDS-PAGE. Nat Protoc 1: 16-22.
37. Wu Z, Zheng S, Li Z, Tan J, Yu Q, (2011) E2F1 suppresses Wnt/beta-catenin activity through transactivation of beta-catenin interacting protein ICAT. Oncogene 30: 3979-3984.
38. Lussier CR, Brial F, Roy SA, Langlois MJ, Verdu EF, et al. (2010) Loss of hepatocyte-nuclear-factor-1alpha impacts on adult mouse intestinal epithelial cell growth and cell lineages differentiation. PLoS One 5: e12378.
39. Liu Z, Lu CL, Cui LP, Hu YL, Yu Q, et al. (2012) MicroRNA-146a modulates TGF-beta1-induced phenotypic differentiation in human dermal fibroblasts by targeting SMAD4. Arch Dermatol Res 304: 195-202.
40. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, et al. (2009) PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest 89: 47-58.
41. Lv ZM, Wang Q, Wan Q, Lin JG, Hu MS, et al. (2011) The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells. PLoS One 6: e22806.
42. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
43. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
44. Park CW, Kim HW, Ko SH, Lim JH, Ryu GR, et al. (2007) Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. J Am Soc Nephrol 18: 1227-1238.
45. Herrera GA, (2006) Plasticity of mesangial cells: a basis for understanding pathological alterations. Ultrastruct Pathol 30: 471-479.
46. He W, Dai C, Li Y, Zeng G, Monga SP, et al. (2009) Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776.
47. He W, Kang YS, Dai C, Liu Y, (2011) Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22: 90-103.
48. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, et al. (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347.
49. Saal S, Harvey SJ, (2009) MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens 18: 317-323.
50. Kaucsar T, Racz Z, Hamar P, (2010) Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease. Adv Drug Deliv Rev 62: 1390-1401.
51. Long J, Wang Y, Wang W, Chang BH, Danesh FR, (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 285: 23457-23465.
52. Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, et al. (2011) miR-200a Prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes 60: 280-287.
53. Wang B, Komers R, Carew R, Winbanks CE, Xu B, et al. (2012) Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 23: 252-265.
54. Kato M, Arce L, Wang M, Putta S, Lanting L, et al. (2011) A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells. Kidney Int 80: 358-368.
55. Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, et al. (2000) Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 14: 1741-1749.
56. Graham TA, Clements WK, Kimelman D, Xu W, (2002) The crystal structure of the beta-catenin/ICAT complex reveals the inhibitory mechanism of ICAT. Mol Cell 10: 563-571.
57. Gottardi CJ, Gumbiner BM, (2004) Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. Am J Physiol Cell Physiol 286: C747-756.
58. Stow JL, (2004) ICAT is a multipotent inhibitor of beta-catenin. Focus on "role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions". Am J Physiol Cell Physiol 286: C745-746.
59. Abe H, Tominaga T, Matsubara T, Abe N, Kishi S, et al. (2012) Scleraxis modulates bone morphogenetic protein 4 (BMP4)-Smad1 protein-smooth muscle alpha-actin (SMA) signal transduction in diabetic nephropathy. J Biol Chem 287: 20430-20442.
60. Du R, Huang C, Bi Q, Zhai Y, Xia L, et al. (2010) URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin. Biochem Biophys Res Commun 391: 135-141.
61. Kantharidis P, Wang B, Carew RM, Lan HY, (2011) Diabetes complications: the microRNA perspective. Diabetes 60: 1832-1837.
62. Chung AC, Huang XR, Meng X, Lan HY, (2010) miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21: 1317-1325.
63. Kim TH, Kim SH, Seo JY, Chung H, Kwak HJ, et al. (2011) Blockade of the Wnt/beta-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med 223: 45-54.
64. Li W, Zhu C, Chen X, Li Y, Gao R, et al. (2011) Pokeweed antiviral protein down-regulates Wnt/beta-catenin signalling to attenuate liver fibrogenesis in vitro and in vivo. Dig Liver Dis 43: 559-566.